Back to results
US 8,557,814 B2Granted
mTOR inhibitor salt forms
AssigneeOSI Pharmaceuticals, Inc.
InventorsArlindo L. Castelhano, Kristen Michelle Mulvihill, Gary C. Visor
Life of this patent
Estimating the term…
Abstract
Salt forms of mTOR inhibitors of the Formula (I): and methods of preparation, formulation, and use in treating disease.
Claims18
A pharmaceutically acceptable salt of trans-4-[4-amino-5-(7-methoxy-1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane carboxylic acid, wherein the salt is selected from sodium, calcium, L-arginine, magnesium, potassium, N,N-diethylethanolamine, N-methyl-D-glucamine, or tromethamine.
Dependencies are inferred from the claim text.